GE to demonstrate at RSNA 2014 ultrasound hardware and software.
GE will demonstrate at RSNA 2014 a versatile portfolio of ultrasound hardware and software.
The vScan with Dual Probe is the first of its kind 2-in-1 probe, GE said, which offers health care providers many uses for pocket ultrasound. It houses two transducers in a single probe which should allow clinicians to see shallow and deep views of the body without changing probes.
Volusion E10 with HDlive technology is GE’s newest system and features a curved matrix electronic 4D probe designed specifically for OB/GYN, the world’s first, according to GE. The system provides 2D and 3D/4D images with increased penetration, GE said.
Invenia ABUS has an acquisition process that uses 3D ultrasound technology to image women with dense breast tissue in approximately 15 minutes with features that conform to a woman’s anatomy, GE said.
Shear Wave elastography is a new tool for the LOGIQ E9 with XDclear Shear Wave elastography and offers an advanced level of diagnostic information to help evaluate tissue stiffness, GE said. The LOGIQ E9 ultrasound system uses a focused burst of acoustic energy from the transducer to generate Shear Waves that produce quantitative measurements and a color coded elastogram. These quantifiable exams provide enhanced benefits as compared with traditional strain elastography, GE said.
Vivid E9 with XDclear was built from the Vivid E9 platform and designed to enhance image quality in 2D, 4D, color, and Doppler. The image clarity improvements can be especially helpful for patients that have been difficult to scan in the past, like obese patients, GE said.
Venue 50 is a portable ultrasound that delivers crisp images quickly with the simplicity of a tablet, GE said. The touch user interface offers easy gel-and-go scanning and is designed for speed, GE said.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.